cubes

Press Releases 2014

PsychoGenics Receives License to the Cntnap2 Knockout Mouse Model from the Weizmann Institute

June 9, 2014 – Tarrytown, New York. - PsychoGenics Inc. announced today that it has received a license to use the Cntnap2 knockout mouse from Yeda R&D Co. Ltd., the technology transfer company of the Weizmann Institute of Science. Read More.

PsychoGenics Achieves Another Milestone in its Drug Discovery Collaboration with Sunovion

May 12, 2014 – Tarrytown, New York. - PGI Drug Discovery LLC (PsychoGenics), today announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion. Read More.

PsychoGenics and Roche Expand Their Drug Discovery Partnership

April 22, 2014 – Tarrytown, New York. - PGI Drug Discovery LLC (PsychoGenics) announced that it has expanded its CNS drug discovery partnership with Roche and extended the agreement for another five years. Read More.

PsychoGenics Obtains a Non-Exclusive License to the rTg4510 Tauopathy Mouse Model

January 31, 2014 – Tarrytown, New York. - PsychoGenics Inc. announced today that it has obtained licenses to the rTg4510 tauopathy mouse from Mayo Clinic and TET Systems GmbH & Co. KG (TET Systems). The rTg4510 mouse expresses the P301L mutation in the tau gene associated with frontotemporal dementia and Parkinsonism linked to chromosome 17. Transgene expression in this model is induced via the tetracycline-operon responsive element (licensed from TET Systems) and is reversibly suppressed after treatment with doxycycline. Read More.

 

  • PsychoGenics
  • 765 Old Saw Mill River Road, Tarrytown, NY 10591
  • tel: (914) 406-8019
  • fax: (914) 593-0645